Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Urology
|
March 16, 2015
Predicting Outcomes in Bladder Cancer: Are We Any Good and Could We Do Better?
Jo Cresswell, A Hugh Mostafid
The Journal of Urology
|
April 25, 2020
Editorial Comment
Anna Walsh, Ben Challacombe, Jo Cresswell
Translational Andrology and Urology
|
January 29, 2019
T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
Andrew Brodie, Nadine McCauley, Jo Cresswell, et al.
BJU International
|
February 27, 2022
Ethnic minority urologists and allies: equity, diversity and belonging
Joe Philip, Banan Mustafa, Odunayo Kalejaiye, et al.
European Urology Oncology
|
July 17, 2019
A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER
Tim Dudderidge, Jacqui Stockley, Ghulam Nabi, et al.
BMJ Open
|
June 11, 2026
Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer
Eva Kagenaar, David Gibran Lugo-Palacios, Hannah Bromley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 2008
Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer
Priyamal Silva, Nick J Slevin, Philip Sloan, et al.
European Urology Open Science
|
November 1, 2021
Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit
Wei Shen Tan, Jeffrey J Leow, Maya Marchese, et al.
European Urology
|
October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)
John D Kelly, Wei Shen Tan, Nuria Porta, et al.
BJU International
|
November 30, 2023
Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year
Zoe Rogers, Adam Glaser, James W F Catto, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Urology
|
March 16, 2015
Predicting Outcomes in Bladder Cancer: Are We Any Good and Could We Do Better?
Jo Cresswell, A Hugh Mostafid
The Journal of Urology
|
April 25, 2020
Editorial Comment
Anna Walsh, Ben Challacombe, Jo Cresswell
Translational Andrology and Urology
|
January 29, 2019
T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
Andrew Brodie, Nadine McCauley, Jo Cresswell, et al.
BJU International
|
February 27, 2022
Ethnic minority urologists and allies: equity, diversity and belonging
Joe Philip, Banan Mustafa, Odunayo Kalejaiye, et al.
European Urology Oncology
|
July 17, 2019
A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER
Tim Dudderidge, Jacqui Stockley, Ghulam Nabi, et al.
BMJ Open
|
June 11, 2026
Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer
Eva Kagenaar, David Gibran Lugo-Palacios, Hannah Bromley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 2008
Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer
Priyamal Silva, Nick J Slevin, Philip Sloan, et al.
European Urology Open Science
|
November 1, 2021
Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit
Wei Shen Tan, Jeffrey J Leow, Maya Marchese, et al.
European Urology
|
October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)
John D Kelly, Wei Shen Tan, Nuria Porta, et al.
BJU International
|
November 30, 2023
Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year
Zoe Rogers, Adam Glaser, James W F Catto, et al.
Page
of 2